Healthcare · Drug Manufacturers - General
Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Biotech · OBV Trend | DOWN 100% | OBV Trend — on-balance-volume accumulation. BIIB ranks #3 of 8 in Biotech (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Regime Switch | DOWN 86% | Regime Switch — the market looks trending, so it ranked on Momentum. BIIB ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · RSI Mean-Reversion | UP 86% | RSI Mean-Reversion — oversold up / overbought down. BIIB ranks #2 of 8 in Biotech (86% bullish percentile, RSI 62), so the agent calls it UP for the next session. |
| Biotech · Trend Strength | DOWN 86% | Trend Strength — OLS slope of log price. BIIB ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Momentum Acceleration | UP 57% | Momentum Acceleration — trend speeding up. BIIB ranks #4 of 8 in Biotech (57% bullish percentile, signal +1.8%), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 43% | Donchian — position within the Donchian channel. BIIB ranks #5 of 8 in Biotech (43% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · MACD | UP 14% | MACD — MACD histogram momentum crossover. BIIB ranks #7 of 8 in Biotech (14% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 14% | Momentum — trailing return (trend-following). BIIB ranks #7 of 8 in Biotech (14% bullish percentile, signal +9.0%), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP | Volume Thrust — volume-confirmed accumulation. BIIB ranks #8 of 8 in Biotech (0% bullish percentile), so the agent calls it UP for the next session. |
Best agents on BIIB (graded record)
| Mean-Reversion Agent | 100% | 1/1 correct | UP |
| Biotech · LightGBM | 54% | 13/24 correct | UP |
| Biotech · Breakout | 53% | 8/15 correct | UP |
| Biotech · OBV Trend | 53% | 8/15 correct | DOWN |
| Biotech · Relative Strength | 53% | 8/15 correct | DOWN |
| Biotech · Bollinger Reversion | 53% | 9/17 correct | DOWN |
| Biotech · Dual Momentum | 52% | 11/21 correct | UP |
| Biotech · SOTA Ensemble | 50% | 17/34 correct | UP |
| Biotech · Regime Switch | 50% | 6/12 correct | DOWN |
| Biotech · Vol-Adjusted Momentum | 50% | 4/8 correct | DOWN |
Recent news
| 2026-08-25 | 3 Reasons to Sell BIIB and 1 Stock to Buy Instead · yf_tkr_BIIB |
| 2026-08-25 | Veeva Vault CRM seleccionado por Biogen · pr_newswire_finance |
| 2026-08-25 | RBC Capital raises Biogen stock price target on lupus drug potential - Investing.com · Investing.com |
| 2026-08-25 | RBC Capital raises Biogen stock price target on lupus drug potential - Investing.com India · Investing.com India |
| 2026-08-25 | RBC Capital raises Biogen stock price target on lupus drug potential - Investing.com UK · Investing.com UK |
| 2026-08-25 | RBC Capital raises Biogen stock price target on lupus drug potential - Investing.com · Investing.com |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。